Report post

Should you buy Checkpoint Therapeutics (CKPT) stock?

There are currently 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CKPT shares. View CKPT analyst ratings or view top-rated stocks. What is Checkpoint Therapeutics' stock price target for 2024? 5 equities research analysts have issued 1 year price objectives for Checkpoint Therapeutics' stock.

Where is Checkpoint Therapeutics headquartered?

Its product portfolio includes CK-301, CK-101, CK-103, CK-302, and Anti-CAIX. The company was founded on November 10, 2014 and is headquartered in Waltham, MA. View Checkpoint Therapeutics, Inc. CKPT stock quote prices, financial information, real-time forecasts, and company news from CNN.

What is the average price target for Checkpoint Therapeutics (CTC)?

The average price target represents an increase of 891.85% from the last closing price of $1.84. Checkpoint Therapeutics, Inc. currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by four brokerage firms.

The World's Leading Crypto Trading Platform

Get my welcome gifts